Full video transcriptClick to expand
Auto-generated transcript of @rivi.rl's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00If you really don't give a shit about your health and care about performance, here's the best brain stack.
- 0:05You need atomics for increase, focus, learning and memory.
- 0:08You need to select or reduce anxiety.
- 0:10You need dihexas just for overall better cognitive function.
- 0:12Testosterone for this drive and motivation.
- 0:14Need a lot of stimulants, caffeine, some stuff.
- 0:17I probably won't name.
- 0:18These are really underrated ones.
- 0:20You don't want to sell or you need to sell big bonus.
- 0:23You're about to hit it.
- 0:23You really, you really need it.
- 0:25In those situations you're PT-141.
- 0:28It's just an instant dope means.
- 0:29You just want to go get it.
- 0:30Then you need Mod C, NAD+, L-wooded Dion, and BPC-157.
- 0:35So you don't get cancer.
Are peptides actually 'not that bad for you'? Let's look at the data
Quick answer
The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement. No dosing context, contraindications, or medical supervision is mentioned, and the claim that BPC-157 prevents cancer has no supporting clinical evidence. At least two compounds in the stack (PT-141, testosterone) require a prescription in the United States and are not appropriate for unsupervised self-administration.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Are peptides actually 'not that bad for you'? Let's look at the data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
VYLEESI (bremelanotide injection) FDA Prescribing Information
Bremelanotide (PT-141) is FDA-approved as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women; approval is limited to that indication.
FDA
Bremelanotide for Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Pivotal RECONNECT studies: two double-blind placebo-controlled Phase 3 trials (1,267 women) showing improved sexual desire and reduced distress versus placebo.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Are peptides actually 'not that bad for you'? Let's look at the data is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Are peptides actually 'not that bad for you'? Let's look at the data" from Rivi. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement.
The reason this review is not generic is the source wording and the canonical claim label "peptides in all reality none are really that bad for you if you re sm." In this clip, the useful excerpt is: "If you really don't give a shit about your health and care about performance, here's the best brain stack." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against SCENESSE (afamelanotide implant) FDA Prescribing Information (2019), Afamelanotide for Erythropoietic Protoporphyria (2015), and Melanotan II injection resulting in systemic toxicity and rhabdomyolysis (2012), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement. No dosing context, contraindications, or medical supervision is mentioned, and the claim that BPC-157 prevents cancer has no supporting clinical evidence. At least two compounds in the stack (PT-141, testosterone) require a prescription in the United States and are not appropriate for unsupervised self-administration.
- BPC-157 has no peer-reviewed human clinical trial data supporting cancer prevention, and some animal research flags concerns about its interaction with tumor angiogenesis.
- PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder in women; using it as a motivation enhancer is an off-label application with no controlled evidence in healthy populations.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- BPC-157 has no peer-reviewed human clinical trial data supporting cancer prevention, and some animal research flags concerns about its interaction with tumor angiogenesis.
- PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder in women; using it as a motivation enhancer is an off-label application with no controlled evidence in healthy populations.
- Dihexa has zero published human safety data. Its entire evidence base is rodent studies, which makes casual recommendation in a TikTok stack deeply irresponsible.
- Caffeine plus L-theanine is the one combination in this list with solid human RCT support: Haskell et al. (2008) in Biological Psychology showed improved attention and alertness versus either alone.
- NAD+ precursor research is real and growing, including Yoshino et al. (2021) in Science showing metabolic benefits in older adults, but it is a long way from being a validated nootropic stack component.
- Stacking prescription compounds (testosterone, PT-141) with experimental peptides and stimulants without medical supervision creates interaction risks that have not been studied and cannot be predicted from individual compound data alone.
- The hashtags 'highticketsales' and 'makemoneyonline' in a peptide video signal a sales context, not a health education one. Treat the content accordingly.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @rivi.rl actually say?
The creator rattled off a list of substances they call the "best brain stack" for anyone who "don't give a shit about your health and care about performance." The stack includes semax (called "atomics" in garbled audio), selank, dihexa, testosterone, caffeine, PT-141, Mod GRF or similar peptides, NAD+, L-theanine (likely the "L-wooded Dion" in the transcript), and BPC-157. The most alarming claim came at the end: that BPC-157 is needed "so you don't get cancer." That is a direct disease-prevention claim, and it has no clinical evidence behind it. The video's caption says "this isn't real advice" but still pitches a specific multi-substance protocol to 13,400 viewers, several of whom are presumably taking notes.
Does the science back this up?
Some pieces, partially. Most of it, no. Semax has genuine preclinical data for neuroprotection, primarily in Russian literature. Selank has small human trials suggesting anxiolytic effects without sedation (Uchakina et al., 2014, Eksperimental'naya i Klinicheskaya Farmakologiya). Dihexa is a different story: it's an angiotensin IV analog with rodent cognition data, and essentially zero peer-reviewed human safety data. Testosterone does affect motivation and drive in hypogonadal individuals, that part is not controversial. NAD+ precursors have a legitimate longevity research base (Yoshino et al., 2021, Science). L-theanine paired with caffeine has actual randomized trial support for attention (Haskell et al., 2008, Biological Psychology). BPC-157 has interesting animal healing data but no completed human clinical trials as of 2024. The "don't get cancer" claim for BPC-157 is not supported by any published evidence and directly contradicts responsible communication standards.
What did they get wrong (or right)?
Wrong: The BPC-157 cancer prevention claim is the most serious problem here. There is no peer-reviewed human evidence that BPC-157 prevents cancer. Some animal studies actually raised concerns about its effect on tumor growth in oncological contexts, which makes this claim worse than just unsupported. PT-141 (bremelanotide) is described as "an instant dope means" for motivation, but its approved use is for hypoactive sexual desire disorder in women. Its effect on general motivation or cognitive drive in healthy people is unsubstantiated in controlled research. Dihexa is presented casually despite having no published human pharmacokinetic or safety data. Wrong also: stacking unlicensed peptides with testosterone and stimulants without any mention of medical supervision is genuinely risky. Right, partially: the caffeine plus L-theanine combination is well-supported. Selank's anxiolytic profile is at least grounded in real pharmacology. NAD+ precursors have credible aging research behind them. Credit where it's due, the creator is not entirely making things up, but they're filling large gaps with confidence the evidence doesn't support.
What should you actually know?
Several substances in this stack are not FDA-approved for the uses described and are not legally available as retail supplements in the United States. Dihexa has no human safety profile. PT-141 is a prescription drug approved for a specific indication in women, not a general motivation booster. Stacking peptides with testosterone and stimulants without monitoring creates unpredictable pharmacological interactions that no responsible clinician would recommend without labs, history, and follow-up. The hashtags "highticketsales" and "makemoneyonline" sitting alongside "nootropic" and "peptide" are worth noticing. This video exists in a sales funnel, not a clinical context. Anyone considering any of these substances should consult a licensed provider who can assess individual risk, contraindications, and legality. The disclaimer "this isn't real advice" does not reduce the real-world impact of specific substance recommendations reaching 13,400 viewers.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rivi · TikTok creator
13.4K views on this video
In all reality none are really that bad for you if you’re smart. This isn’t real advice, do your research. #nootropic #peptide #highticketsales #makemoneyonline
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about bpc-157 has no peer-reviewed human clinical trial data supporting cancer?
BPC-157 has no peer-reviewed human clinical trial data supporting cancer prevention, and some animal research flags concerns about its interaction with tumor angiogenesis.
What does the video say about pt-141 (bremelanotide)?
PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder in women; using it as a motivation enhancer is an off-label application with no controlled evidence in healthy populations.
What does the video say about dihexa has zero published human safety data. its entire evidence?
Dihexa has zero published human safety data. Its entire evidence base is rodent studies, which makes casual recommendation in a TikTok stack deeply irresponsible.
What does the video say about caffeine plus l-theanine?
Caffeine plus L-theanine is the one combination in this list with solid human RCT support: Haskell et al. (2008) in Biological Psychology showed improved attention and alertness versus either alone.
What does the video say about nad+ precursor research?
NAD+ precursor research is real and growing, including Yoshino et al. (2021) in Science showing metabolic benefits in older adults, but it is a long way from being a validated nootropic stack component.
What does the video say about stacking prescription compounds (testosterone, pt-141) with experimental peptides?
Stacking prescription compounds (testosterone, PT-141) with experimental peptides and stimulants without medical supervision creates interaction risks that have not been studied and cannot be predicted from individual compound data alone.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rivi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.